US FDA's proposed 510(k) policy change could have ‘devastating’ impact on industry
This article was originally published in Clinica
Executive Summary
A policy change that the US FDA is proposing in the medical devices arena could have a devastating effect on emerging companies, with particularly drastic implications for sponsors of devices subject to 510(k) clearance.